Rank 76 • AI & Clinical Intelligence
Brainomix
Creates AI-driven imaging software to optimize treatment decisions and accelerate care pathways for stroke and lung diseases.
Visit website- Signal Score
- 83.9
- Total raised
- $30M
- Stage
- Series B
- Founded
- 2010
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
Their signal
A spinout of Oxford, Brainomix has revolutionized stroke care across European health systems with high-quality validation and automated diagnostic intelligence.
Signal Score 83.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.